Birchview Capital’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Birchview Capital’s Portfolio CMTA Stock Details CMTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-222,000	Closed	-$5.79M	–	57
2019 Q1	$5.79M	Hold	222,000	–	–	3.63%	3
2018 Q4	$2.61M	Buy	222,000 +100,000	+82%	+$1.24M	2.47%	4
2018 Q3	$1.36M	Buy	122,000 +54,000	+79%	+$568K	0.88%	14
2018 Q2	$895K	Buy	68,000 +30,000	+79%	+$486K	0.61%	19
2018 Q1	$576K	Buy	38,000 +16,000	+73%	+$260K	0.38%	24
2017 Q4	$418K	Hold	22,000	–	–	0.25%	26
2017 Q3	$372K	Buy	+22,000	New	+$360K	0.19%	27

Birchview Capital's CMTA Position: Q2 2019 in Review

Birchview Capital sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 222,000 shares — an estimated $5.79M sold.

Birchview Capital first reported a position in CMTA in Q3 2017 and held it in 7 quarters. The position peaked at $5.79M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

Birchview Capital reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
Birchview Capital sold 222,000 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $5.79M.
Birchview Capital first reported a position in Clementia Pharmaceuticals Inc. in Q3 2017 and held it in 7 quarters.
Birchview Capital's Clementia Pharmaceuticals Inc. position peaked at $5.79M in Q1 2019.
0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Birchview Capital's 13F filing for Q2 2019, filed 6 Aug 2019.